Novartis
E141505
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
All labels observed (11)
How this entity was disambiguated
This entity first appeared as the object of triple T1169596 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Novartis Context triple: [Ionis Pharmaceuticals, hasCollaborationWith, Novartis]
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
C.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Novartis Target entity description: Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
C.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
Statements (53)
| Predicate | Object |
|---|---|
| instanceOf |
multinational corporation
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| areaServed | worldwide ⓘ |
| businessModel | research-based pharmaceutical company ⓘ |
| CEO | Vas Narasimhan ⓘ |
| country | Switzerland ⓘ |
| foundedAsMergerOf |
Ciba-Geigy
ⓘ
Sandoz ⓘ |
| foundedBy |
Ciba-Geigy
ⓘ
Sandoz ⓘ |
| hasResearchCenter |
Basel
ⓘ
linked to:
Basel-Stadt
Cambridge, Massachusetts ⓘ Shanghai ⓘ |
| headquartersLocation |
Basel
ⓘ
linked to:
Basel-Stadt
Switzerland ⓘ |
| inception | 1996 ⓘ |
| industry |
biotechnology
ⓘ
healthcare ⓘ pharmaceuticals ⓘ |
| ISIN | CH0012005267 ⓘ |
| languageOfWorkOrName |
English
ⓘ
French ⓘ German ⓘ |
| legalForm | Aktiengesellschaft ⓘ |
| location |
Basel
ⓘ
linked to:
Basel-Stadt
Switzerland ⓘ |
| notableDrug |
Cosentyx
ⓘ
Entresto ⓘ Gleevec ⓘ Kymriah ⓘ Lucentis ⓘ Tasigna ⓘ |
| productOrService |
biosimilars
ⓘ
cardiovascular drugs ⓘ cell and gene therapies ⓘ generic medicines ⓘ immunology drugs ⓘ oncology drugs ⓘ ophthalmology drugs ⓘ prescription medicines ⓘ |
| stockExchange |
New York Stock Exchange
ⓘ
SIX Swiss Exchange ⓘ |
| subsidiary |
Alcon
ⓘ
Sandoz ⓘ |
| therapeuticArea |
cardiovascular diseases
ⓘ
immunology ⓘ neuroscience ⓘ oncology ⓘ ophthalmology ⓘ |
| tickerSymbol |
NOVN
ⓘ
NVS ⓘ |
| website | https://www.novartis.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Novartis Description of subject: Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
Referenced by (54)
Full triples — surface form annotated when it differs from this entity's canonical label.